Sequenom Announces Distribution Agreement with Invitrogen for South and Central America
News May 01, 2008
Sequenom, Inc. has announced that it has entered into an agreement with Invitrogen Corporation under which Invitrogen will be the exclusive distributor for Sequenom's MassARRAY® systems and consumable products in Central and South America. Financial terms of the agreement were not disclosed.
"Among our top priorities is expanding our geographic reach and this agreement provides us with an entree into Central and South America, regions where we see a substantial opportunity but have had little exposure," said Sequenom's Senior Vice President, Sales & Marketing Michael Monko. "We are set to enter these regions utilizing the substantial resources available through Invitrogen and are pleased to be working with Invitrogen's first-rate sales team."
Separately, Sequenom announced the sale of its first MassARRAY system in South America. The system was sold to a sugarcane consortium to be used in biofuel research and development. Brazil is a leader in this area, producing the cheapest ethanol in the world. Sugarcane is a highly efficient raw material for the production of ethanol and is available in abundance in Brazil. Sequenom's technology will be used as part of an effort to engineer an even more productive line of sugarcane for ethanol production, the company has said.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.